Drugs / PRO-155
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03521791 | Dec 2017 → Sep 2018 | pterygium | Laboratorios Sophia S.A de C.V. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRO-155 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03521791 ↗ |
| Route | Other | “The pharmacological intervention will consist of the instillation of the ophthalmological solution in the conjunctival cul-de-sac” NCT03521791 ↗ |